Advanced search
Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Email Registration
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
  1. Homepage
  2. Equities
  3. Canada
  4. Toronto Stock Exchange
  5. MCI Onehealth Technologies Inc.
  6. Financials
    DRDR   CA58118M1086

MCI ONEHEALTH TECHNOLOGIES INC.

(DRDR)
  Report
Delayed Toronto Stock Exchange  -  10:53:42 2023-02-08 am EST
0.6800 CAD   -5.56%
02/07MCI Onehealth Provides Update on Subsidiary Khure Health
GL
02/07MCI Onehealth Provides Update on Subsidiary Khure Health
GL
01/17MCI Onehealth Announces Changes to Management Team Structure
MT
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
Valuation
Fiscal Period: December 2021 2022 2023
Capitalization1 61,136,136,1
Enterprise Value (EV)1 55,741,843,4
P/E ratio -3,79x-1,80x-5,14x
Yield ---
Capitalization / Revenue 1,28x0,66x0,58x
EV / Revenue 1,17x0,76x0,70x
EV / EBITDA -12,0x-5,24x32,0x
Enterprise Value (EV) / FCF -7,02x-4,88x-8,45x
FCF Yield -14,2%-20,5%-11,8%
Price to Book ---
Nbr of stocks (in thousands) 48 90550 07550 075
Reference price (CAD) 1,250,720,72
Announcement Date 03/31/2022--
1 CAD in Million
Estimates
Income Statement Evolution (Annual data)
Fiscal Period: December 2019 2020 2021 2022 2023
Net sales1 46,338,647,854,762,3
EBITDA1 -4,52-4,64-7,981,36
Operating profit (EBIT)1 --3,29-15,1-17,4-8,75
Operating Margin --8,54%-31,5%-31,8%-14,0%
Pre-Tax Profit (EBT)1 ---16,3-18,7-10,1
Net income1 -0,12--15,7-20,2-10,1
Net margin -0,26%--32,8%-36,9%-16,2%
EPS2 ---0,33-0,40-0,14
Free Cash Flow1 -4,14-7,93-8,56-5,13
FCF margin -10,7%-16,6%-15,6%-8,24%
FCF Conversion -91,6%171%107%-378%
Dividend per Share -----
Announcement Date 12/11/202003/30/202103/31/2022--
1 CAD in Million
2 CAD
Estimates
Income Statement Evolution (Quarterly data)
Fiscal Period: December 2021 Q3 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4
Net sales1 12,613,913,013,812,615,2
EBITDA1 -1,82-1,51-2,42-2,94-2,15-0,58
Operating profit (EBIT)1 -5,33-4,55-4,76-5,06-5,12-2,66
Operating Margin -42,2%-32,7%-36,6%-36,7%-40,7%-17,6%
Pre-Tax Profit (EBT)1 -5,47-4,69-5,04-5,45-5,59-2,99
Net income1 -5,44-4,94-4,32-4,23-9,10-2,99
Net margin -43,0%-35,4%-33,2%-30,6%-72,3%-19,7%
EPS2 -0,11-0,10-0,09-0,08-0,18-0,06
Dividend per Share ------
Announcement Date 11/15/202103/31/202205/16/202208/15/202211/14/2022-
1 CAD in Million
2 CAD
Previous periodNext period
Estimates
Balance Sheet Analysis
Fiscal Period: December 2019 2020 2021 2022 2023
Net Debt1 ---5,747,31
Net Cash position1 --5,42--
Leverage (Debt / EBITDA) --1,17x-0,72x5,39x
Free Cash Flow1 -4,14-7,93-8,56-5,13
ROE (Net Profit / Equities) -----
Shareholders' equity1 -----
ROA (Net Profit / Asset) -----
Assets1 -----
Book Value Per Share -----
Cash Flow per Share -----
Capex1 -0,090,830,420,93
Capex / Sales -0,22%1,74%0,77%1,49%
Announcement Date 12/11/202003/30/202103/31/2022--
1 CAD in Million
Estimates
Key data
Capitalization (CAD) 36 054 145
Capitalization (USD) 26 826 400
Net sales (CAD) 47 817 000
Net sales (USD) 35 578 654
Number of employees 400
Sales / Employee (CAD) 119 543
Sales / Employee (USD) 88 947
Free-Float 16,5%
Free-Float capitalization (CAD) 5 949 018
Free-Float capitalization (USD) 4 426 418
Avg. Exchange 20 sessions (CAD) 2 758
Avg. Exchange 20 sessions (USD) 2 052
Average Daily Capital Traded 0,01%
EPS & Dividend